HLA-B and myelodysplastic syndrome: Pediatric-onset patients with HLA-B*14:02 did not differ in MDS rate from patients lacking HLA-B*14:02 (1 of 10, 10% vs. 1 of 87, 1.1%, P = 0.197) (albeit with the limitation of statistical power given the low rate of pediatric MDS).